Company intelligence / Profile preview

Zyplast

Palo Alto, California, United States

Ownership: Private
Development stage: Other

Overview

Collagen Corporation was a pioneer in the field of medical aesthetics and biomaterials, best known for developing the first FDA-approved injectable dermal fillers, Zyderm and Zyplast. These products utilized highly purified bovine collagen to treat facial wrinkles, scars, and other soft tissue defects. The company's technology focused on the processing of bovine dermal collagen into a biocompatible, injectable form that could integrate with human tissue. Following a series of industry consolidations, the company and its product portfolio were eventually integrated into Allergan (now part of AbbVie).

Therapeutic areas: Dermatology
Modalities: BiologicDeviceProtein
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Zyplast.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zyplast.

Explore the full profile